{"database": "lobbying", "table": "lobbying_activities", "rows": [[1694811, "a98e10bf-60cf-4fda-8806-bbf581e4d1f7", "Q2", "THE CHARLES GROUP, LLC", 53458, "NEWPORT BRAIN RESEARCH LABORATORY, INC.", 2015, "second_quarter", "VET", "Discussing effective treatments for veterans suffering from PTSD and other related effects such as substance abuse issues", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2015-07-14T14:39:56.820000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1694811"], "units": {}, "query_ms": 0.42376795317977667, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}